On Wednesday, Canada decisively announced a retaliatory measure that encapsulates the escalating tensions between itself and the United States under the Trump administration. With a staggering 25% tariff on over $20 billion worth of American goods, Canada is signaling a firm stand against economic intimidation. This situation marks a significant chapter in the ongoing saga
0 Comments
As the smartwatch industry finds itself grappling with a significant downturn, a recent report from Counterpoint highlights a sobering 7% decrease in global shipments year-over-year (YoY) for 2024. This drop, marking the first decline in smartwatch sales globally, portends deeper issues within the market. The challenges facing well-established brands like Apple are alarming, as they
0 Comments
In a striking pivot from conventional policies, Health and Human Services Secretary Robert F. Kennedy Jr. proposes a radical shift in the way we approach food safety and public health. At a recent roundtable with leading food industry executives, Kennedy voiced his commitment to eliminating “the worst ingredients” from our food supply, citing artificial dyes
0 Comments
At first glance, Flying Lotus’ film “Ash” emerges as yet another entry into the growing pantheon of cosmic horror. However, as the narrative unfolds, viewers are confronted with deeper, more unsettling truths intertwined with the genre’s convention. Eiza González stars as Riya, an astronaut thrust into an alien landscape devoid of identity and haunted by
0 Comments
In an age where globalization has brought unprecedented interconnectivity and economic collaboration, the recent imposition of tariffs by U.S. President Donald Trump on steel and aluminum imports marks a significant regression in trade policy. This move is not unique; it is part of a concerning trend where nations increasingly resort to protectionist measures under the
0 Comments
As a growing concern in society, Alzheimer’s disease places an immense emotional burden on individuals and families alike. The advent of new treatments, namely lecanemab and donanemab, has sparked a sense of optimism among researchers and patients. Approved within the last couple of years, these therapies represent a significant shift in the ongoing battle against
0 Comments